Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL1163117 Target Snapshot

Cyclin-dependent kinase-like 3 · SINGLE PROTEIN · Homo sapiens

270Compounds
92Assays
1Approved Drugs
94.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q8IVW4. Use UniProt Q8IVW4 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q8IVW4 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Cyclin-dependent kinase-like 3 as ChEMBL target CHEMBL1163117, mapped to UniProt Q8IVW4. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Cyclin-dependent kinase-like 3
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL1163117
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q8IVW4
Cyclin-dependent kinase-like 3
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Cyclin-dependent kinase-like 3 is the right protein anchor across sources, using UniProt Q8IVW4 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelCyclin-dependent kinase-like 3
UniProt AccessionQ8IVW4
Component TypeProtein
Sequence Length592 aa

Cyclin-dependent kinase-like 3

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Cyclin-dependent kinase-like 3, mapped to UniProt Q8IVW4. Sequence length is 592 aa.

Mapped IDQ8IVW4
Review nameCyclin-dependent kinase-like 3
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Approved
1
Phase III
4
Phase II
4
Phase I
Assay Mix

Activity Type Distribution

IC5013.0
KD81.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL5426285 9.3 IC50 0.5 Preclinical
CHEMBL574738 8.41 Kd 3.9 Preclinical
CHEMBL574738 8.15 IC50 7.1 Preclinical
CHEMBL5190023 6.84 IC50 143.0 Preclinical
CHEMBL572878 6.46 Kd 350.0 Clinical
CHEMBL603469 6.37 Kd 430.0 Clinical
CHEMBL1336 6.31 Kd 490.0 Approved
CHEMBL5393904 6.17 IC50 668.5 Preclinical
CHEMBL379218 5.96 Kd 1100.0 Preclinical
CHEMBL388978 5.96 IC50 1100.0 Preclinical
Distribution

pChEMBL Value Distribution

3
5.0
4
5.5
6
6.0
1
6.5
0
7.0
0
7.5
2
8.0
0
8.5
1
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

SORAFENIB
CHEMBL1336
Approved 2005
Assay Landscape

Assay Landscape

92
Total Assays
12
Tested Compounds
1
Assay Types
Binding — 92 assays, 12 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 73 12 6.5
assay format 17 0
cell-based format 2 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine